Lack of alteration of endogenous nitric oxide pathway during prolonged nitric oxide inhalation in intensive care unit patients

Critical Care Medicine

Volumn 33, Issue 5, 2005, Pages 1008-1014

  Lukaszewicz, Anne Claire ^a   Mebazaa, Alexandre ^a   Callebert, Jacques ^a   Matéo, Joaquim ^a   Gatecel, Claire ^a   Kechiche, Hakim ^a   Maistre, Geneviève ^b   Carayon, Alain ^b   Baudin, Bruno ^c   Payen, Didier ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

Acute lung injury; Atrial natriuretic peptide; Cyclic guanosine monophosphate; Endothelin; Inhaled nitric oxide; Right ventricular failure

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; NITRATE; NITRIC OXIDE; NITRITE; RENIN;

ACUTE LUNG INJURY; ADULT; AGED; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; LUNG VENTILATION PERFUSION RATIO; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION;

ADMINISTRATION, INHALATION; ADULT; AGED; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; ENDOTHELIN-1; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NITRIC OXIDE; RESPIRATORY DISTRESS SYNDROME, ADULT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 21044437814     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000163233.00458.DD     Document Type: Article

References (46)

1. Beloucif S, Payen D: A European survey of the use of inhaled nitric oxide in the ICU. Working Group on Inhaled NO in the ICU of the European Society of Intensive Care Medicine. Intensive Care Med 1998; 24:864-877
2. Steudel W, Hurford W, Zapol W: Inhaled nitric oxide: Basic biology and clinical applications. Anesthesiology 1999; 91:1090-1121
3. Haddad E, Lowson S, Johns R, et al: Use of inhaled nitric oxide perioperatively and in intensive care patients. Anesthesiology 2000; 92:1821-1825
4. Puybasset L, Rouby JJ, Mourgeon E, et al: Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 1994; 20:319-327
5. Rossaint R, Falke K, Lopez F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
6. Schreiber M, Gin-Mestan K, Marks J, et al: Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003; 349:2099-2107
7. Mebazaa A, Karpati P, Renaud E, et al: Acute right ventricular failure - From pathophysiology to new treatments. Intensive Care Med 2004; 30:185-196
8. Cuthbertson B, Galley H, Webster N: Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit Care Med 2000; 28:1736-1741
9. Kermarrec N, Zunic P, Beloucif S, et al: Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Role of cyclic guanosine 5′-monophosphate. Am J Respir Crit Care Med 1998; 158:833-839
10. Gries A, Herr A, Kirsch S, et al: Inhaled nitric oxide inhibits platelet-leukocyte interactions in patients with acute respiratory distress syndrome. Crit Care Med 2003; 31:1697-1704
11. Sokol J, Jacobs S, Bohn D: Inhaled nitric oxide for acute hypoxic respiratory failure in children and adults: A meta-analysis. Anesth Analg 2003; 97:989-998
12. Taylor R, Zimmerman J, Dellinger R, et al: Low-dose inhaled nitric oxide in patients with acute lung injury. A randomized controlled trial. JAMA 2004; 291:1603-1609
13. Kinsella J, Parker T, Ivy D, et al: Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. J Pediatr 2003; 142:397-401
14. Parker JD: Nitrate tolerance, oxidative stress and mitochondrial function: Another worrisome chapter on the effects of organic nitrates. J Clin Invest 2004; 113:352-354
15. Sydow K, Daiber A, Oelze M, et al: Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 2004;. 113:482-489
16. Ghofrani HA, Wiedemann R, Rose F, et al: Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: Responders versus nonresponders. Eur Respir J 2002; 19:664-671
17. Wedgwood S, McMullan D, Bekker J, et al: Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 2001; 89:357-364
18. McMullan D, Bekker J, Johengen M, et al: Inhaled nitric oxide-induced rebound pulmonary hypertension: Role for endothelin-1. Am J Physiol Heart Circ Physiol 2001; 280:H777-H785
19. Pearl J, Nelson D, Raake J, et al: Inhaled nitric oxide increases endothelin-1 levels: A potential cause of rebound pulmonary hypertension. Crit Care Medicine 2002; 30:89-93
20. Cuthbertson BH, Dellinger P, Dyar OJ, et al: UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS. Intensive Care Med 1997; 23:1212-1218
21. Sieffert E, Ducros L, Losser MR, et al: Inhaled nitric oxide fraction is influenced by both the site and the mode of administration. J Clin Monit Comput 1999; 15:509-517
22. B'chir A, Mebazaa A, Losser M, et al: Intravenous almitrine bismesylate reversibly induces lactic acidosis and hepatic dysfunction in patients with acute lung injury. Anesthesiology 1998; 89:823-830
23. Beghetti M, Sparling C, Cox P, et al: Inhaled NO inhibits platelet aggregation and elevates plasma but not intraplatelet cGMP in healthy human volunteers. Am J Physiol Heart Circ Physiol 2003; 285:H637-H342
24. Giovannoni G, Land J, Keir G, et al: Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem 1997; 34:193-198
25. Deray G, Chanson P, Maistre G, et al: Atrial natriuretic factor in patients with acromegaly. Eur J Clin Pharmacol 1990; 38:409-413
26. Baudin B, Bénéteau-Burnat B, Crayon B, et al: Automated kinetic assay of angiotensin-converting enzyme on Synchron CX-4. Clin Chem Enzym Comms 1995; 7:41-48
27. Payen D, Muret J, Beloucif S, et al: Inhaled nitric oxide, almitrine infusion, or their coadministration as a treatment of severe hypoxemic focal lung lesions. Anesthesiology 1998; 89:1157-1168
28. Cholley B, Hilbert U, Guinard N, et al: Improvement of extreme hypoxemia during end-stage congenital heart disease using nasal nitric oxide. Anesthesiology 1998; 89:1586-1587
29. Watanabe H, Kakihana M, Ohtsuka S, et al: Platelet cyclic GMP. A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance. Circulation 1993; 88:29-36
30. Tsutamoto T, Kinoshita M, Ohbayashi Y, et al: Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure. Circulation 1994; 90:823-829
31. Zwissler B, Kemming G, Merkel M, et al: Response to inhaled nitric oxide (NO) is not associated with changes of plasma cGMP levels in patients with acute lung injury. Eur J Med Res 1999; 4:463-467
32. Moncada S, Palmer RMJ, and Higgs EA: Nitric oxide: physiology, physiopathology, and pharmacology. Pharmacol Rev 1991; 43:109-142
33. Han TH, Qamirani E, Nelson AG, et al: Regulation of nitric oxide consumption by hypoxic red blood cells. Proc Natl Acad Sci U S A 2003; 100:12504-12509
34. Wennmalm A, Benthin G, Edlund A, et al: Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 1993; 73:1121-1127
35. Stamler J, Singel D, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science 1992; 258:1898-1902
36. Groeneveld P, Kwappenberg K, Langermans J, et al: Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis. Intensive Care Med 1996; 22:1197-1202
37. Strand O, Leone A, Giercksky K, et al: Nitric oxide indices in human septic shock. Crit Care Med 2000; 28:2779-2785
38. Cardella J, Keshavjee S, Bai X-H, et al: Increased expression of nitric oxide synthase in human lung transplants after nitric oxide inhalation. Transplantation 2004; 77:886-890
39. Ross G, Oishi P, Azakie A, et al: Endothelial alterations during inhaled NO in lambs with pulmonary hypertension: Implications for rebound hypertension. Am J Physiol Lung Cell Mol Physiol 2005; 288:L27-L35
40. Chen L, He H, Fernandez Mondejar E, et al: Endothelin-1 and nitric oxide synthase in short rebound reaction to short exposure to inhaled nitric oxide. Am J Physiol Heart Circ Physiol 2001; 281:H124-H131
41. Jungersten L, Edlund A, Petersson A, et al: Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. Clin Physiol 1996; 16:369-379
42. Wagner F, Buz S, Knosalla C, et al: Modulation of circulating endothelin-1 and big endothelin by nitric oxide inhalation following left ventricular assist device implantation. Circulation 2003; 108(Suppl 1): II278-II284
43. Frelin C, Guedin D: Why are circulating concentrations of endothelin-1 so low? Cardiovasc Res 1994; 28:1613-1622
44. Wenz M, Steinau R, Gerlach H, et al: Inhaled nitric oxide does not change transpulmonary angiotensin II formation in patients with acute respiratory distress syndrome. Chest 1997; 112:478-483
45. Huang H, Arnal J, Llorens-Cortes C, et al: Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction. Circ Res 1994; 75:454-461
46. Baudin B, Berard M, Carrier J, et al: Vascular origin determines angiotensin I-converting enzyme expression in endothelial cells. Endothelium 1997; 5:73-84